Spinal device developer Axiomed has raised $1 million in a new round of equity financing, according to an SEC filing posted this week. The Malden, Mass.-based company produces the Freedom cervical disc and Freedom lumbar disc. The Freedom cervical and lumbar discs are designed to be one-piece total disc replacement devices which enable neck pain […]
AxioMed Spine Corp.
MASSDEVICE ON CALL — The FDA is looking for medical device companies to participate in its "Experiential Learning Program," so that the agency’s reviewers can get a 1st-hand look into medtech design and manufacturing.
Participating companies would host tours for healthcare regulators as part of a training mechanism to give the reviewers a sense of the medtech development life-cycle and the "challenges faced throughout development, testing, manufacturing, and clinical use," according to an FDA notice.
Medical device company AxioMed Spine Corp., has raised $3.6 million from current and new investors.
The Ohio-based spinal orthopedics company’s devices focus on restoring spinal function to treat degenerative spine diseasea,according to a press release.
By Mary Vanac
AxioMed Spine Corp. raised $14.5 million in Series D funding to help the company finish enrolling patients for a pivotal U.S. clinical study of its lumbar disc replacement and earn CE Mark approval for its cervical disc in Europe.
The Garfield Heights, Ohio-based developer of next-generation spinal disc replacements said it raised the money in two tranches from new and existing investors.